UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 216

Sortiert nach

Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries

The Lancet infectious diseases, 2019-01, Vol.19 (1), p.67-75

2019

Volltextzugriff (PDF)

High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries

PloS one, 2021-01, Vol.16 (1), p.e0241899

2021

Volltextzugriff (PDF)

Guideline recommendations and antimicrobial resistance: the need for a change

BMJ open, 2017-07, Vol.7 (7), p.e016264-e016264

2017

Volltextzugriff (PDF)

The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines

Frontiers in pharmacology, 2020-09, Vol.11, p.578000

2020

Volltextzugriff (PDF)

How to improve antibiotic awareness campaigns: findings of a WHO global survey

BMJ global health, 2019-05, Vol.4 (3), p.e001239

2019

Volltextzugriff (PDF)

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

Annals of internal medicine, 2007-10, Vol.147 (8), p.553

2007

Volltextzugriff (PDF)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO

BMJ open, 2022-02, Vol.12 (2), p.e053349-e053349

2022

Volltextzugriff (PDF)

World Health organization guidelines for management of acute stress, PTSD, and bereavement: key challenges on the road ahead

PLoS medicine, 2014-12, Vol.11 (12), p.e1001769

2014

Volltextzugriff (PDF)

Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems

International journal of infectious diseases, 2020-12, Vol.101, p.361-366

2020

Volltextzugriff (PDF)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

PloS one, 2015-05, Vol.10 (5), p.e0124719-e0124719

2015

Volltextzugriff (PDF)

Comment on: American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34(Suppl. 1):S11-S61

Diabetes care, 2011-05, Vol.34 (5), p.e53; author reply e54-e53

2011

Volltextzugriff (PDF)

Tough decisions on essential medicines in 2015

Bulletin of the World Health Organization, 2015-04, Vol.93 (4), p.283-284

2015

Volltextzugriff (PDF)

Antibiotic Use Among Hospitalized Children and Neonates in China: Results From Quarterly Point Prevalence Surveys in 2019

Frontiers in pharmacology, 2021-03, Vol.12, p.601561

2021

Volltextzugriff (PDF)

Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials

PloS one, 2014-10, Vol.9 (10), p.e109915-e109915

2014

Volltextzugriff (PDF)

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system

BMC health services research, 2005-03, Vol.5 (1), p.25-25, Article 25

2005

Volltextzugriff (PDF)

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

The Lancet infectious diseases, 2018-01, Vol.18 (1), p.18-20

2018

Volltextzugriff (PDF)

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV

Journal of Immunology Research, 2015-01, Vol.2015, p.435141-13

2015

Volltextzugriff (PDF)

Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”

Journal of Immunology Research, 2017-01, Vol.2017, p.4583487-3

2017

Volltextzugriff (PDF)

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

The New England journal of medicine, 2021-02, Vol.384 (6), p.497-511

2021

Volltextzugriff (PDF)

Measuring antibiotic availability and use in 20 low- and middle-income countries

Bulletin of the World Health Organization, 2020-03, Vol.98 (3), p.177-187C

2020

Volltextzugriff (PDF)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?

Journal of pharmaceutical policy and practice, 2015-10, Vol.8 (S1), p.O14-O14, Article O14

2015

Volltextzugriff (PDF)

Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study

The Lancet infectious diseases, 2021-10, Vol.21 (10), p.1429-1440

2021

Volltextzugriff (PDF)

Essential medicines for cancer: WHO recommendations and national priorities

Bulletin of the World Health Organization, 2016-10, Vol.94 (10), p.735-742

2016

Volltextzugriff (PDF)

Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

The Lancet infectious diseases, 2019-12, Vol.19 (12), p.1278-1280

2019

Volltextzugriff (PDF)

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Annals of internal medicine, 2009-08, Vol.151 (4), p.264

2009

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Humans
(134)
Life Sciences & Biomedicine
(124)
Female
(40)
General & Internal Medicine
(35)
Medicine, General & Internal
(34)
Italy
(32)
Male
(25)
Public Health
(23)
Aged
(22)
Middle Aged
(22)
Patients
(22)
Biological And Medical Sciences
(21)
Science & Technology - Other Topics
(19)
Adult
(18)
Antibiotics
(18)
Public, Environmental & Occupational Health
(18)
Medical Sciences
(17)
Infectious Diseases
(16)
World Health Organization
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries

High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries

Guideline recommendations and antimicrobial resistance: the need for a change

The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines

How to improve antibiotic awareness campaigns: findings of a WHO global survey

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO

World Health organization guidelines for management of acute stress, PTSD, and bereavement: key challenges on the road ahead

Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

Comment on: American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34(Suppl. 1):S11-S61

Tough decisions on essential medicines in 2015

Antibiotic Use Among Hospitalized Children and Neonates in China: Results From Quarterly Point Prevalence Surveys in 2019

Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV

Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Measuring antibiotic availability and use in 20 low- and middle-income countries

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?

Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study

Essential medicines for cancer: WHO recommendations and national priorities

Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Suchergebnisse filtern